Improving consent understanding with a video tool
Part of Blood & lymphatic, Cancer clinical trials.
This study is testing a new way to explain clinical trial information to people using a video or online tool, to see if it helps them understand better. You may be able to join if you are an English-speaking adult living in the U.S.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to read and understand English.
- You must be at least 18 years old.
- You must identify as White or Black.
- You must live in the United States.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a virtual community health educator to help cancer patients and their caregivers learn more about and join clinical trials. If you have had cancer or care for someone who has, this program might help you find trials that fit.
This study aims to help people learn more about cancer clinical trials and become more comfortable with the idea of joining one. It is open to adults connected to Karmanos Cancer Institute who want to learn and give their permission to participate.
This study uses telemedicine (video or phone visits) to help older adults with cancer, especially those in underserved communities, get better care. If you're 65 or older and starting a new cancer treatment, you may be able to join from home in English, Spanish, or Chinese.
This study looks at how patients and providers talk with each other about immunotherapy at Winship Cancer Institute. It may help improve communication and support for cancer care.
This study tests a digital tool that uses pictures and simple visuals to help you understand your cancer treatment options. The goal is to make the experience better for you, your family, and your doctors.
This study looks at how doctors and patients talk about clinical trials, with the goal of improving conversations for everyone involved. If you join, you'll fill out questionnaires about your experiences.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.